NuvOx develops a first-in-class drug that delivers oxygen to tissue. After Phase IIa clinical trials in stroke and glioblastoma, we are conducting a Phase IIb trial in glioblastoma and entering into a Phase IIb stroke and a Phase Ib respiratory trials.